Cytology of Body Cavity Effusions: Classification and Interpretation

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Body cavity effusions are classified into transudates, modified transudates, exudates, hemorrhagic, and chylous effusions based on total protein concentration and nucleated cell count, with thresholds varying by species and laboratory.
• Cytologic evaluation is critical for differentiating benign reactive mesothelial cells from neoplastic populations and for identifying inflammatory cells, infectious agents (e.g., bacteria, fungi, Leishmania amastigotes), and neoplastic cells.
• Accurate effusion classification requires integrating fluid analysis (protein, cell count, cytology) with signalment, history, physical examination, and potentially ancillary diagnostics such as fluid culture, biochemical analysis, flow cytometry, or immunocytochemistry.
• Sample collection into EDTA for cell count/cytology and plain tubes for protein, with prompt processing (within 30-60 minutes) and appropriate smear preparation (e.g., cytocentrifugation for low cellularity), is essential to prevent cell degeneration and artifact.
• Distinguishing reactive mesothelial hyperplasia from neoplasia, identifying iatrogenic blood contamination versus true hemorrhage, and correlating effusion findings with serum biochemistry are common challenges requiring careful interpretation and potentially advanced testing.
• Species differences, particularly higher protein concentrations in feline effusions and greater reactive atypia of feline mesothelial cells, necessitate species-specific reference intervals and interpretive considerations.

Body cavity effusions are a common diagnostic challenge in small animal practice. Pleural, peritoneal, and pericardial fluids accumulate through distinct pathophysiologic mechanisms, and cytologic evaluation is the single most informative laboratory test for characterizing the underlying process. This article provides a practical framework for classifying effusions as transudates, modified transudates, exudates, hemorrhagic effusions, or chylous effusions, and for interpreting the cellular populations within each category. It is written for practicing veterinarians who collect and evaluate fluid samples in-house or who need to interpret laboratory reports critically.

The diagnostic question that drives effusion analysis is straightforward: is this fluid a passive filtrate, an inflammatory product, a vascular or lymphatic leak, or a neoplastic effusion? Answering that question requires integrating total protein concentration, nucleated cell count, and cytologic morphology with the clinical presentation. This article covers the physiologic basis of effusion formation, the classification scheme most widely used in veterinary medicine, and the cytologic features that distinguish benign reactive mesothelial cells from neoplastic populations. Species differences between dogs and cats are highlighted where they affect interpretation.

At a Glance

Classification thresholds vary by reference laboratory and species. The values above follow the scheme published in the MSD Veterinary Manual and represent the framework most veterinary clinical pathologists apply in practice.

Physiology of Effusion Formation

Fluid movement across capillary membranes follows Starling forces. Hydrostatic pressure drives fluid out of capillaries, while plasma oncotic pressure, maintained largely by albumin, draws fluid back in. The lymphatic system removes excess interstitial fluid and returns it to the venous circulation. Effusions develop when one or more of these forces are disrupted.

Hypoalbuminemia reduces plasma oncotic pressure and produces a pure transudate. Increased hydrostatic pressure from congestive heart failure, portal hypertension, or venous obstruction produces a similar fluid. Lymphatic obstruction, as occurs with neoplasia or granulomatous inflammation, impairs fluid clearance and typically generates a modified transudate. Inflammatory mediators increase vascular permeability and allow protein and leukocytes to escape into the body cavity, producing an exudate. Hemorrhagic effusions result from vascular disruption, and chylous effusions from leakage of intestinal lymph into the pleural or peritoneal space.

Classification Systems

The traditional veterinary classification divides effusions into transudates, modified transudates, and exudates based on total protein concentration and nucleated cell count. This scheme is pragmatic and clinically useful, but it has limitations. A chronic transudate often becomes a modified transudate as mesothelial cells slough and mild inflammation develops. An early exudate may have a cell count below the conventional threshold. The classification should therefore be treated as a starting point for interpretation, not a final diagnosis.

The American Society for Veterinary Clinical Pathology publishes laboratory standards that address sample handling, quality assurance, and reference interval validation. These guidelines emphasize that fluid analysis results are only as reliable as the preanalytical handling. Samples that clot, sit for hours before processing, or are collected from a cavity with prior instrumentation may yield misleading cell counts and cytologic artifacts.

Sample Collection and Handling

Fluid should be collected aseptically into an EDTA tube for cell count and cytology. A second sample in a plain tube is useful for total protein measurement by refractometer, though the refractive index of the fluid must be interpreted with caution because fibrinogen and other proteins can elevate the reading. If bacterial culture is anticipated, a sterile sample should be collected into a culture tube before antibiotics are administered.

Samples should be processed within 30 to 60 minutes of collection. Cells degenerate rapidly in fluid, particularly neutrophils, and delayed processing can convert a cellular exudate into a poorly cellular sample with karyorrhectic debris. If immediate processing is impossible, refrigeration slows degeneration but does not prevent it. Smears should be made from well-mixed fluid, and concentration techniques such as cytocentrifugation are recommended for low-cellularity samples.

Cytologic Evaluation

Mesothelial Cells

Mesothelial cells line the serosal surfaces of body cavities. They are normally present in small numbers in effusions and appear as round to polygonal cells with moderate amounts of basophilic cytoplasm and a central nucleus. Reactive mesothelial cells, stimulated by chronic irritation or inflammation, become larger, more pleomorphic, and may form clusters or sheets. Binucleation and multinucleation are common. These reactive changes can mimic neoplasia, and the distinction is one of the most difficult in veterinary cytology.

A case report describing a dog with scapular osteosarcoma and pleural effusion illustrates this challenge. Initial cytology of the pleural fluid was interpreted as a modified transudate with atypical cells attributed to mesothelial hyperplasia and dysplasia. Only after cytochemical staining for alkaline phosphatase and immunohistochemistry were the cells correctly identified as neoplastic osteoblasts Neoplastic pleural effusion and intrathoracic metastasis of a scapular osteosarcoma in a dog. This case underscores the value of ancillary testing when mesothelial atypia is present, particularly in a patient with imaging findings that suggest an underlying mass.

Inflammatory Cells

Neutrophils predominate in septic exudates and in many nonseptic inflammatory effusions. Degenerate neutrophils with swollen, pale nuclei suggest bacterial infection, while nondegenerate neutrophils are more consistent with sterile inflammation such as feline infectious peritonitis or pancreatitis. Macrophages appear in chronic effusions and in response to hemorrhage or foreign material. Lymphocytes are the predominant cell type in chylous effusions and in some viral or neoplastic processes.

Neoplastic Cells

Neoplastic effusions may contain cells from primary mesotheliomas, carcinomas, or sarcomas. Carcinomas of the lung, mammary gland, and abdominal organs are the most common sources of neoplastic effusions in dogs and cats. Cytologic features of malignancy include marked anisocytosis, anisokaryosis, prominent nucleoli, and atypical mitotic figures. However, the sensitivity of cytology for detecting neoplasia in effusions is imperfect, and a negative cytologic result does not exclude neoplastic disease.

Infectious Agents

Effusion cytology can identify infectious organizms directly. Amastigotes of Leishmania infantum have been identified in peritoneal fluid of dogs with leishmaniasis, sometimes in association with a mixed inflammatory population and serum protein abnormalities Presumed monoclonal gammopathy and parasitized immune cells in peritoneal fluid of a dog with canine leishmaniasis. Bacterial rods and cocci may be visible in septic effusions, and fungal organizms such as Blastomyces or Cryptococcus can be found in endemic regions.

Diagnostic Approach to Effusions

The classification of an effusion as a transudate, modified transudate, exudate, hemorrhage, or chyle is the first step, but it is not the endpoint. The complete diagnostic sequence integrates signalment, history, physical examination, fluid analysis, and cytology to identify the underlying mechanism. Each step narrows the differential list and directs subsequent testing.

Begin with the total protein concentration and nucleated cell count. These two values assign the effusion to a category. A pure transudate has a low protein concentration and low cellularity, reflecting altered hydrostatic or oncotic pressure. A modified transudate has intermediate values and suggests chronic effusion, early inflammation, or neoplasia. An exudate has high protein and high cellularity, indicating inflammation or neoplasia with tissue invasion. The distinction between modified transudate and exudate is not absolute, and overlap occurs. The ASVCP quality assurance guidelines emphasize that laboratory standards and reference intervals must be validated for the species and method used, because point-of-care refractometers and automated analyzers can disagree on protein measurement.

The next decision point is the cell population. Neutrophil-rich effusions with degenerative change support sepsis. Macrophage-rich effusions with fewer neutrophils suggest chronic inflammation, feline infectious peritonitis, or prior hemorrhage. Lymphocyte-rich effusions raise concern for chyle or lymphosarcoma. The presence of atypical cells triggers a search for neoplasia, but mesothelial hyperplasia can mimic malignancy. The case of a dog with scapular osteosarcoma and pleural effusion illustrates this trap: initial cytology was interpreted as mesothelial hyperplasia and dysplasia, and only after cytochemistry for alkaline phosphatase and cell pellet immunohistochemistry were neoplastic osteoblasts identified in the fluid. This multidisciplinary diagnostic approach to neoplastic pleural effusion demonstrates that effusion cytology alone may miss malignancy, and that ancillary testing should be pursued when clinical suspicion remains high despite benign cytology.

Effusion Classification Table

The protein thresholds vary by source. The MSD Veterinary Manual provides species-specific reference ranges and cautions that feline effusions often have higher protein concentrations than canine effusions for the same pathophysiologic process. Use the table as a framework, not a rigid rule.

Diagnostic Algorithm for Common Causes

The algorithm below prioritizes tests by diagnostic yield and cost. It assumes standard in-house laboratory capability.

1. Measure total protein, nucleated cell count, and specific gravity. Note fluid color and turbidity.
2. If the fluid is milky or turbid, perform a chyle test. Compare the fluid triglyceride concentration to serum triglyceride. Fluid triglyceride greater than serum triglyceride confirms chyle.
3. If the fluid is bloody, determine whether bleeding is active. Centrifuge a sample. Clear supernatant with a red cell pellet indicates recent hemorrhage. Xanthochromic supernatant indicates chronic hemorrhage. Clot formation suggests recent bleeding with intact coagulation.
4. If the fluid is a pure transudate, measure serum albumin and total protein. Hypoalbuminemia below approximately 1.5 g/dL in dogs supports a diagnosis of protein-losing enteropathy or nephropathy. Evaluate liver function and portal circulation.
5. If the fluid is a modified transudate, pursue imaging. Thoracic radiographs, abdominal ultrasound, or echocardiography identify mass lesions, cardiac disease, or organomegaly. Consider fluid culture if bacterial infection is suspected despite low cellularity.
6. If the fluid is an exudate, perform cytology to characterize the inflammatory population. Degenerate neutrophils with intracellular bacteria confirm sepsis and mandate culture and susceptibility testing. Nondegenerate neutrophils with macrophages suggest feline infectious peritonitis, and a coronavirus antibody titer or reverse transcriptase polymerase chain reaction on the fluid may be indicated.
7. If atypical cells are present, obtain a second opinion or submit the fluid for review by a clinical pathologist. Ancillary testing includes immunocytochemistry, flow cytometry, or cytochemistry. The osteosarcoma case above shows that cytochemistry and cell pellet immunohistochemistry can identify neoplasia that routine cytology misses.
8. If the effusion is chylous, investigate underlying causes. Thoracic radiographs and echocardiography rule out heart disease and mediastinal masses. Idiopathic chylothorax remains a diagnosis of exclusion.

Ancillary Testing and Its Indications

Fluid culture is indicated for exudates with degenerate neutrophils, regardless of whether bacteria are visible. Aerobic and anaerobic culture should be requested. In cases where prior antibiotics were administered, culture yield decreases and cytology becomes more important.

Biochemical testing of effusion fluid has limited utility but specific indications. Creatinine and potassium in peritoneal fluid compared to serum help confirm uroabdomen. Bile acids or bilirubin in peritoneal fluid support bile peritonitis. Amylase and lipase in peritoneal fluid are poorly specific and rarely change management.

Flow cytometry and immunocytochemistry are reserved for suspected lymphoma or carcinoma. These tests require adequate cellularity and appropriate sample handling. The ASVCP guidelines recommend that samples for immunophenotyping be collected in EDTA and processed promptly to preserve cell viability.

Species and Clinical Context Modifications

The diagnostic approach changes with species and patient status. In cats, effusions are frequently associated with feline infectious peritonitis, cardiomyopathy, and neoplasia. Feline effusions often have higher protein concentrations than canine effusions, and the distinction between modified transudate and exudate is less reliable. In horses, peritoneal effusions are common in colic, and the nucleated cell count threshold for surgical intervention is lower than in small animals. In cattle, peritonitis secondary to traumatic reticuloperitonitis is a leading cause of peritoneal effusion.

Patient status changes the urgency of the workup. A dyspneic dog with pleural effusion requires therapeutic drainage before extensive diagnostics. A hypotensive cat with peritoneal effusion needs stabilization and point-of-care ultrasound before fluid analysis is completed. The AVMA practice resources emphasize that diagnostic planning must account for patient stability and owner resources.

Available equipment changes the correct choice. In-house analyzers provide rapid cell counts but may not differentiate cell types. A refractometer measures total protein but cannot distinguish albumin from globulins. If a laboratory is not available, cytology slides can be prepared and submitted for review, but the fluid should be refrigerated and submitted within 24 hours.

Documentation and Reporting

Record the following for every effusion: volume collected, gross appearance, total protein, nucleated cell count, and cytologic description. Note the presence of bacteria, atypical cells, or infectious agents. The MSD Veterinary Manual recommends that cytology reports include a description of cell types, their relative proportions, and any degenerative changes. A diagnosis of neoplasia should be stated as suspected or confirmed based on the level of evidence. In cases where cytology is inconclusive, recommend additional testing instead of overinterpreting limited findings.

The case of canine leishmaniasis with peritoneal effusion illustrates the value of combining effusion cytology with serum protein profiling. The peritoneal fluid cytology in that case revealed a mixed inflammatory population with intra- and extracellular amastigotes, while serum electrophoresis showed a presumed monoclonal gammopathy. This combination of findings supported a diagnosis of advanced leishmaniasis and highlighted that infectious agents may be present even when the inflammatory pattern is nonspecific. Effusion cytology should always include a careful search for infectious organizms, particularly in endemic regions or when the patient has a history of travel.

Recognized Complications and Failure Modes

Effusion analysis carries several failure modes that can misdirect diagnosis. The most consequential is misclassification of a neoplastic effusion as reactive mesothelial hyperplasia. Mesothelial cells undergoing reactive change display marked anisocytosis, multinucleation, and prominent nucleoli, features that overlap substantially with carcinoma. A reported case of scapular osteosarcoma with pleural metastasis illustrates this trap: initial pleural fluid cytology was attributed to mesothelial hyperplasia and dysplasia, and only a multidisciplinary approach combining cytochemistry, cell pellet immunohistochemistry, and transmission electron microscopy identified neoplastic osteoblasts in the fluid (Neoplastic pleural effusion and intrathoracic metastasis of a scapular osteosarcoma in a dog: a multidisciplinary integrated diagnostic approach). The discriminating features favouring neoplasia include cell clusters with loss of cell-to-cell cohesion, nuclear-to-cytoplasmic ratios exceeding 0.5, coarse chromatin, and cytoplasmic vacuolation that does not follow a uniform pattern. When doubt persists, alkaline phosphatase cytochemistry on prestained slides can distinguish osteosarcoma from mesothelial or epithelial cells, and cell block preparation with immunohistochemistry should be pursued.

A second failure mode is the false-negative effusion. Low cellularity transudates may contain neoplastic cells in numbers below the threshold of cytologic detection. Repeated sampling after drainage, or submission of a larger volume for cell block preparation, improves yield. Centrifugation and examination of the buffy coat layer of the sediment increases sensitivity for sparse cell populations.

A third failure mode is the misreading of iatrogenic blood contamination as hemorrhagic effusion. Traumatic taps introduce platelets and fresh erythrocytes, whereas true hemorrhagic effusions show erythrophagia, hemosiderin-laden macrophages, and the absence of platelets. The presence of erythrophagic macrophages confirms hemorrhage of at least several hours duration.

Common Errors and Corrective Actions

Less experienced clinicians frequently rely on color and turbidity alone to classify effusions. A chylous effusion may appear milky, but so may a highly cellular exudate or a pseudochylous effusion. Triglyceride and cholesterol measurement discriminates these: chyle has triglyceride concentrations exceeding serum values, while pseudochylous effusions have high cholesterol with low triglycerides. Centrifugation clarifies the distinction, as chylous fluid remains turbid after spinning while cellular exudates clear.

Another recurring error is the failure to correlate fluid analysis with serum biochemistry. A modified transudate with low protein concentration may be dismissed as insignificant when the serum albumin is severely decreased. The effusion is then the presenting sign of hypoalbuminaemia, and the diagnostic focus should shift to protein-losing enteropathy or nephropathy. Similarly, a peritoneal effusion with a mixed inflammatory population in a dog from an endemic region should prompt a careful search for Leishmania amastigotes within macrophages, as parasitized immune cells may be present alongside a predominantly neutrophilic and lymphocytic profile (Presumed monoclonal gammopathy and parasitized immune cells in peritoneal fluid of a dog with canine leishmaniasis).

A third error is the overinterpretation of a single atypical cell cluster. Degenerate neutrophils, reactive mesothelial cells, and even fungal elements can mimic malignancy. The corrective action is to require multiple independent criteria for neoplasia and to seek a second opinion when the diagnosis would alter therapy or prognosis.

Limitations of Current Evidence

The evidence base for effusion cytology rests heavily on case series and expert opinion instead of prospective trials. Sensitivity and specificity figures for cytologic diagnosis of neoplastic effusions vary widely between studies and are not established for most tumor types. The distinction between reactive mesothelial hyperplasia and well-differentiated mesothelioma remains one of the most difficult in veterinary cytology, and even experienced pathologists disagree on a proportion of cases. Ancillary testing such as immunocytochemistry and flow cytometry improves diagnostic accuracy but is not standardized across laboratories, and reference intervals for many markers are lacking. The American Society for Veterinary Clinical Pathology guidelines address quality assurance for laboratory testing but do not resolve interpretive controversies. Expert opinion still differs on the value of routine bacterial culture of effusions in the absence of intracellular bacteria, and on the threshold for recommending thoracoscopy or laparoscopy when cytology is non-diagnostic.

Referral, Consultation, and Reporting

Referral to a specialist is warranted when cytology reveals atypical cells that cannot be confidently classified, when the effusion recurs rapidly after drainage, or when the suspected diagnosis requires advanced imaging or tissue biopsy for confirmation. Clinical pathology laboratory consultation is appropriate before discarding a sample as non-diagnostic, as cell block preparation or immunocytochemistry may salvage diagnostic information. Regulatory reporting obligations vary by jurisdiction and species. Where infectious agents of public health or trade significance are identified or suspected, the WOAH terrestrial animal health standards and local veterinary authorities should be consulted. The American Veterinary Medical Association practice resources provide guidance on professional obligations and documentation standards. The MSD Veterinary Manual offers species-specific reference information that may assist in interpreting unusual findings.

Frequently Asked Questions

How should I proceed when cytology is inconclusive but the effusion is clearly abnormal?

Repeat the fluid analysis after a short interval, as inflammatory and neoplastic processes can evolve rapidly. Submit additional samples for ancillary testing, including bacterial culture, PCR for infectious agents, and flow cytometry or immunocytochemistry when available. The ASVCP quality assurance guidelines emphasize that sample quality and preparation directly affect diagnostic yield, so reassess collection technique and slide preparation before repeating. If the patient is stable, consider imaging-guided biopsy of any visible lesions instead of relying solely on fluid cytology. A multidisciplinary approach, combining imaging findings with cytochemistry and histopathology, may be necessary to reach a definitive diagnosis, as demonstrated in a reported case of neoplastic pleural effusion initially mistaken for mesothelial hyperplasia.

What is the minimum equipment needed to classify an effusion in general practice?

A refractometer, microhematocrit centrifuge, and standard microscope with a good oil immersion lens are sufficient for most classifications. Total protein by refractometer and nucleated cell count by hemocytometer, when combined with cytospin or direct smear evaluation, distinguish transudates from exudates in the majority of cases. If a centrifuge is unavailable, examine a direct smear from the sediment of a refrigerated sample and a feather-edge preparation from the supernatant interface. The MSD Veterinary Manual provides species-specific reference ranges for fluid protein and cell counts that guide interpretation when automated analyzers are not available. Refrigerate samples if analysis is delayed, but note that cell morphology deteriorates within hours, so prepare smears at collection whenever possible.

How does effusion interpretation differ in cats compared with dogs?

Feline effusions require species-specific reference intervals for protein and cell counts, as cats frequently develop modified transudates with lower protein concentrations than dogs. Feline infectious peritonitis produces a characteriztic high-protein, low-cellularity effusion with a globulin-dominant protein profile, and cytology often shows a mixed inflammatory population with neutrophils and macrophages. Chylous effusions are more common in cats, particularly with cardiomyopathy, and may appear as a modified transudate if the triglyceride content is not elevated. The MSD Veterinary Manual notes that feline mesothelial cells exhibit greater reactive atypia than canine cells, increasing the risk of misclassifying hyperplasia as neoplasia. Always measure fluid triglyceride and cholesterol in cats with unexplained pleural effusion before pursuing more invasive diagnostics.

What should I record in the medical record for an effusion analysis?

Record the collection date, site, volume, gross appearance, and whether the sample was anticoagulated. Document the refractometric protein, nucleated cell count, and cytologic description, including the predominant cell types and any atypical features. Note the method of slide preparation and stain used, as these affect interpretation. Include a cytologic interpretation with a differential diagnosis list, and state which ancillary tests were submitted. The AVMA practice resources recommend that medical records support continuity of care and medicolegal defense, so record the rationale for your interpretation and any limitations of the sample. If slides are submitted to a reference laboratory, retain the original preparation and document the laboratory and accession number.

How do I explain a complex effusion diagnosis to a client without causing confusion?

Use the classification category as the anchor, then explain the differential list in order of likelihood. State that the fluid analysis narrows the possibilities but does not always provide a definitive answer, and describe the next diagnostic step in concrete terms. For example, explain that a modified transudate suggests a non-inflammatory cause such as heart failure or a mass, and that imaging or additional fluid tests will distinguish between them. The MSD Veterinary Manual provides plain-language summaries of common effusion causes that can be adapted for client discussions. Avoid quoting cell counts or protein values unless the client asks, and instead focus on what the findings mean for treatment and prognosis. Offer a written summary of the plan.

When should I consider infectious causes of effusion that require special handling or biosafety precautions?

Consider infectious causes when cytology shows intracellular bacteria, fungal organizms, or protozoa, or when the patient has relevant travel history or exposure. Leishmania amastigotes may appear in peritoneal fluid of dogs with advanced disease, often accompanied by a mixed inflammatory response and monoclonal gammopathy on serum electrophoresis. Handle all effusion samples with universal precautions, and notify laboratory staff when a zoonotic agent is suspected. For notifiable diseases, the WOAH terrestrial animal health standards outline reporting obligations that vary by jurisdiction, so consult local veterinary authorities. If a zoonotic agent is confirmed, provide the client with appropriate personal protective guidance and inform any staff who handled the sample.

Related Clinical & Scientific Guides

• Peripheral Blood Smear Evaluation: A Step-by-Step Guide
• Reticulocyte Counts in Veterinary Medicine: Clinical Utility and Interpretation
• Cerebrospinal Fluid Analysis in Veterinary Neurology: Collection and Interpretation

References and Further Reading

• Neoplastic pleural effusion and intrathoracic metastasis of a scapular osteosarcoma in a dog: a multidisciplinary integrated diagnostic approach.. 2017.
• Presumed monoclonal gammopathy and parasitized immune cells in peritoneal fluid of a dog with canine leishmaniasis.. 2026.
• American Society for Veterinary Clinical Pathology Guidelines. American Society for Veterinary Clinical Pathology.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Cytology of Joint Fluid: Collection and Interpretation in Arthropathies
• Cytology of the Liver and Spleen: Diagnostic Utility and Interpretation
• Cytology of the Respiratory Tract: Collection and Interpretation
• Urinalysis in Veterinary Practice: From Collection to Interpretation
• Feline CBC Interpretation: Species-Specific Considerations

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.